NCT02069041: A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer |
|
|
| Completed | 1b | 8 | RoW | Ramucirumab, IMC-1121B, LY3009806, FOLFOX4, FOLFOX4 (leucovorin + fluorouracil + oxaliplatin) | Eli Lilly and Company | Carcinoma, Hepatocellular | 09/16 | 09/16 | | |